The Lot Distribution Report (LDR) SPLs for biologic drugs must be submitted to CBER every six months, unless a waiver is granted for them to be submitted annually. This report should contain bulk, package, and label lot data, along with the bulk manufacturer’s details and product data elements as listed in the drug listing file. Additionally, all packages distributed during the reporting period should be included.